Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO Staging.

Pre-emptive Non-narcotic Pain Medication before Minimally Invasive Surgery in Gynecologic Oncology.

Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial.

State of the science: Uterine sarcomas: From pathology to practice.

When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic.

Surgical and Clinical Reactivation for Elective Procedures during the COVID-19 Era: A Global Perspective.

Levine Cancer Institute Approach to Pandemic Care of Patients With Cancer.

Surgical Decision Making in the Era of COVID-19: A New Set of Rules.

Molecular variations in uterine carcinosarcomas identify therapeutic opportunities.

Corrigendum to "Phase III trials in ovarian cancer: The evolving landscape of front line therapy" [Gynecol. Oncol. 153 (2019) 436-444].